Literature DB >> 31506885

The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.

Lucianne M West1, J Bradley Williams1, Kathleen D Faulkenberg2.   

Abstract

PURPOSE OF REVIEW: A multidisciplinary approach is vital to reduce mortality and hospitalizations in patients with heart failure. As members of the multidisciplinary team, pharmacists are uniquely positioned to care for patients across the spectrum of heart failure. This comprehensive review explores the different facets in which pharmacists can be utilized to impact the care for patients with heart failure, including those with cardiac transplant and left ventricular assist devices (LVADs), in the outpatient setting. RECENT
FINDINGS: Pharmacists can see heart failure patients in a variety of settings to reduce drug therapy-related issues, increase use of guideline-directed medical therapy (GDMT), and reduce hospitalizations. Although there is limited data available, pharmacists have also been described in aiding the therapeutic drug monitoring of warfarin for patients with LVADs and immunosuppression agents in the transplant population. Through collaborative practice agreements, pharmacists can provide progressive services such as titration of GDMT and lab monitoring, in addition to medication reconciliation, education, and review for potential drug-related problems. Pharmacists can increase access to patient care by providing services through distance-visits, shared medical appointments, and home visits.

Entities:  

Keywords:  Heart failure; Outpatient therapy; Pharmacist-based services

Year:  2019        PMID: 31506885     DOI: 10.1007/s11936-019-0750-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  76 in total

1.  Impact of pharmacist interventions on hospital readmissions for heart failure.

Authors:  E C Rainville
Journal:  Am J Health Syst Pharm       Date:  1999-07-01       Impact factor: 2.637

2.  The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.

Authors:  Frederick A Masoudi; Charles A Baillie; Yongfei Wang; W David Bradford; John F Steiner; Edward P Havranek; JoAnne Micale Foody; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2005-10-10

3.  Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2007-03-30

4.  Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents.

Authors:  Ajay Jain; Peter Mills; Laurence M Nunn; Jane Butler; Lisa Luddington; Valerie Ross; Paraic Cliffe; Kulasagaram Ranjadayalan; Adam D Timmis
Journal:  Eur J Heart Fail       Date:  2005-03-16       Impact factor: 15.534

5.  Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study.

Authors:  W A Gattis; V Hasselblad; D J Whellan; C M O'Connor
Journal:  Arch Intern Med       Date:  1999-09-13

6.  Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness.

Authors:  Claudia Bucci; Cynthia Jackevicius; Karen McFarlane; Peter Liu
Journal:  Can J Cardiol       Date:  2003-03-31       Impact factor: 5.223

7.  Community pharmacist outreach program directed at physicians treating congestive heart failure.

Authors:  C J Turner; P Parfrey; K Ryan; R Miller; A Brown
Journal:  Am J Health Syst Pharm       Date:  2000-04-15       Impact factor: 2.637

8.  Pharmaceutical care of patients with congestive heart failure: interventions and outcomes.

Authors:  S Varma; J C McElnay; C M Hughes; A P Passmore; M Varma
Journal:  Pharmacotherapy       Date:  1999-07       Impact factor: 4.705

9.  Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure.

Authors:  C López Cabezas; C Falces Salvador; D Cubí Quadrada; A Arnau Bartés; M Ylla Boré; N Muro Perea; E Homs Peipoch
Journal:  Farm Hosp       Date:  2006 Nov-Dec

10.  Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study.

Authors:  Marcel L Bouvy; Eibert R Heerdink; John Urquhart; Diederick E Grobbee; Arno W Hoes; Hubert G M Leufkens; Arno W Hoe
Journal:  J Card Fail       Date:  2003-10       Impact factor: 5.712

View more
  3 in total

1.  Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Authors:  Alexander J Blood; Christina M Fischer; Liliana E Fera; Taylor E MacLean; Katelyn V Smith; Jacqueline R Dunning; Joshua W Bosque-Hamilton; Samuel J Aronson; Thomas A Gaziano; Calum A MacRae; Lina S Matta; Ana A Mercurio-Pinto; Shawn N Murphy; Benjamin M Scirica; Kavishwar Wagholikar; Akshay S Desai
Journal:  Clin Cardiol       Date:  2019-11-14       Impact factor: 2.882

2.  The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.

Authors:  Martin Schulz; Nina Griese-Mammen; Pia M Schumacher; Stefan D Anker; Friedrich Koehler; Christian Ruckes; Volker Rettig-Ewen; Rolf Wachter; Dietmar Trenk; Michael Böhm; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-07-23

3.  Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study.

Authors:  Birbirsa Sefera; Mestawet Getachew; Yadeta Babu; Firomsa Bekele; Korinan Fanta
Journal:  BMC Cardiovasc Disord       Date:  2022-09-19       Impact factor: 2.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.